Women With Early Breast Cancer Can Wait Up To 12-Weeks For Chemo, Study Finds
SWOG Study To Test Predictive Value Of Circulating Tumor Cells In Breast Cancer
ASCO Updates Guideline On Follow-Up Management
Exercisers May Have Higher Breast Cancer Survival
New Screening Tool Helps GP ID Hereditary BC Risk
Genomic Tests Not Shown To Decrease Deaths, Improve Quality Of Life
ASCO Updates Guideline On Use Of Tumor Markers
Standard Surgical Protocol Improved Endometrial Staging
Lilly Begins Phase III Trial Of Alimta In Extensive SCLC
FDA Approves Avastin For Recurrent NSCLC
NCI-Approved Clinical Trials
Trending Stories
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - CBER Director Vinay Prasad dared to “say no to drugs”
- J. Craig Venter’s work was foundational to cancer advancement of the past 25 years
- Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)









